EcoDrugPlus

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSPLOG00000018865
Gene Symbol: PSMB10
4 Cross references
171 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSPLOG00000022003
Gene Symbol: PSMB2
4 Cross references
220 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSPLOG00000006899
Gene Symbol: PSMB3
3 Cross references
133 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSPLOG00000007693
Gene Symbol: PSMB4
4 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Beta 5

Ensembl ID : ENSPLOG00000010681
Gene Symbol: PSMB5
4 Cross references
218 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSPLOG00000014781
Gene Symbol: PSMB6
4 Cross references
217 Possible Orthologues:

Proteasome 20s Subunit Beta 7

Ensembl ID : ENSPLOG00000015690
Gene Symbol: PSMB7
4 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 8

Ensembl ID : ENSPLOG00000006662
Gene Symbol: PSMB8
4 Cross references
220 Possible Orthologues:

Proteasome 20s Subunit Beta 9

Ensembl ID : ENSPLOG00000006713
Gene Symbol: PSMB9
2 Cross references
212 Possible Orthologues:

Proteasome 26s Subunit Ubiquitin Receptor, Non-Atpase 2

Ensembl ID : ENSPLOG00000010003
Gene Symbol: PSMD2
4 Cross references
222 Possible Orthologues:

Proteasome 26s Subunit Ubiquitin Receptor, Non-Atpase 4

Ensembl ID : ENSPLOG00000021489
Gene Symbol: PSMD4
4 Cross references
270 Possible Orthologues:

Proteasome 26s Subunit, Atpase 1

Ensembl ID : ENSPLOG00000014674
Gene Symbol: PSMC1
4 Cross references
282 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).